Summarized by Plex Health
Last Updated: 03 May 2022

Enasidenib is used to treat acute myeloid leukemia in adults with an IDH2 mutation. When AML has come back or has not enhanced with previous therapy, enasidenib is used. Enasidenib may be used for objectives not provided in this medication guide. If you have symptoms of distinction syndrome within 10 days to 5 months after taking enasidenib, seek medical help right away. You may need to have a negative maternity test prior to starting this treatment. Both men and women making use of enasidenib ought to use birth control to protect against pregnancy. Enasidenib can damage a coming child if the mom or dad is utilizing this medicine. Keep utilizing contraception for a minimum of 2 months after your last dosage. Do not take another dose if you throw up soon after taking enasidenib. You might need frequent clinical tests and your cancer treatments may be delayed based on the results. Take the missed dose on the same day you remember it.

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

** If you believe that content on the Plex is summarised improperly, please, contact us, and we will get rid of it quickly; please, send an email with a brief explanation.

PubChem - CovalentUnitCount

(Table source)
*** If you want us to remove all links leading to your domain from Plex.page and never use your website as a source of the "Online Knowledge", please contact us using a corporate email and we will remove everything in 10 business days.


Plex Page is a Biology & Health Sciences "Online Knowledge Base," where a machine summarizes all the summaries.